Reduction in head size in patients with aspartylglucosaminuria

Acta Neurol Scand. 2005 Nov;112(5):335-7. doi: 10.1111/j.1600-0404.2005.00492.x.

Abstract

Objective: To show that the head may shrink in adult patients with aspartylglucosaminuria (AGU), a neurodegenerative disease.

Method: The head circumference (HC) of 40 adult patients (age at baseline 15 to 47) was measured twice with an interval of 10 years. Of these 40, 21 aged 15-47 and 19 young patients aged 5-14 as well as 40 healthy controls underwent lateral cephalometric radiography.

Results: During 10 years' follow-up, the HC of 26 (65%) had decreased by 1 to 4.5 cm (mean 1.7, P < 0.001). Evaluation of lateral skull radiographs revealed that patients aged 15 or more had significantly thicker skulls than did younger patients (P = 0.015). Mean intracranial length (glabella-opisthocranium) of the patients aged 15 or more was significantly shorter than in patients aged 14 years or less (P = 0.029). These measurements indicated that brain volume had decreased.

Conclusions: Macrocephalia in childhood followed by reduced brain volume in adulthood is evident in patients with AGU and is reflected by a decrease in head size.

MeSH terms

  • Acetylglucosamine / analogs & derivatives*
  • Acetylglucosamine / urine
  • Adolescent
  • Adult
  • Aged
  • Aspartylglucosaminuria*
  • Aspartylglucosylaminase / genetics
  • Cephalometry
  • Child
  • Child, Preschool
  • Dementia / diagnosis
  • Dementia / genetics
  • Disease Progression
  • Female
  • Follow-Up Studies
  • Humans
  • Lysosomal Storage Diseases / diagnosis*
  • Lysosomal Storage Diseases / genetics
  • Male
  • Microcephaly / diagnosis*
  • Microcephaly / urine
  • Reference Values

Substances

  • N-acetylglucosaminylasparagine
  • Aspartylglucosylaminase
  • Acetylglucosamine